Log in
Enquire now
‌

US Patent 7842663 Variants derived from ActRIIB and uses therefor

Patent 7842663 was granted and assigned to Acceleron Pharma on November, 2010 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Acceleron Pharma
Acceleron Pharma
Date Filed
February 4, 2008
Date of Patent
November 30, 2010
Patent Application Number
12012652
Patent Citations Received
‌
US Patent 11884715 Activin receptor type IIB variants and methods of use thereof
0
‌
US Patent 11685770 Stabilized receptor polypeptides and uses thereof
0
‌
US Patent 12024563 ALK7 antagonists and uses thereof
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
7842663
Patent Primary Examiner
‌
Elizabeth C. Kemmerer

Find more entities like US Patent 7842663 Variants derived from ActRIIB and uses therefor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.